Daphne Koller’s AI start­up gets $143M in new cash from a16z, oth­ers

Biotech is be­com­ing sat­u­rat­ed with ma­chine learn­ing com­pa­nies promis­ing to rein­vent and has­ten drug de­vel­op­ment, but few, if any, have amassed the war chest Daphne Koller has.

En­ter­ing Tues­day, the for­mer Stan­ford pro­fes­sor, MacArthur Fel­low­ship re­cip­i­ent, Cours­era founder and chief com­put­ing of­fi­cer of Google’s se­cre­tive an­ti-ag­ing biotech Cal­i­co had raised $100 mil­lion for her AI start­up in­sitro. Now she’s raised $143 mil­lion more.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN